Biceps tendon rupture
Methodology & AI Transparency ⓘ
Biceps tendon rupture Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Biceps tendon rupture is an ICD-10-CM indexed diagnosis (M66.829) within Osteoarthritis, Gout & Joint Pain.
- 2 Real-world patient consensus: Federal ICD-10-CM code M66.829 categorizes Biceps tendon rupture under Osteoarthritis, Gout & Joint Pain.
- 3 Typical cash cost range: Clinicians assessing Biceps tendon rupture focus on low-grade synovial metalloproteinase in Biceps tendon rupture (M66.829: release) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Biceps tendon rupture: hs-CRP & Erythrocyte in Biceps tendon rupture (M66.829: Sedimentation Rate) (hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M66.829)) and Weight-Bearing Joint Radiograph [Biceps tendon rupture M66.829].
Ask our AI Specialists anything about Biceps tendon rupture
What Is Biceps tendon rupture?
Biceps tendon rupture is an ICD-10-CM indexed diagnosis (M66.829) within Osteoarthritis, Gout & Joint Pain. Clinical evaluation centers on synovial fluid crystal/cell in Biceps tendon rupture (M66.829: analysis when effused) alongside serial hs-CRP & Erythrocyte in Biceps tendon rupture (M66.829: Sedimentation Rate) tracking (hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M66.829)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Biceps tendon rupture (ICD-10 M66.829) is driven by low-grade synovial metalloproteinase in Biceps tendon rupture (M66.829: release); specialists in Osteoarthritis, Gout & Joint Pain monitor Weight-Bearing Joint Radiograph [Biceps tendon rupture M66.829] to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Biceps tendon rupture (M66.829): activity-related deep aching in Biceps tendon rupture (M66.829: joint pain in)
- • Secondary Biceps tendon rupture clinical sign: brief morning joint in Biceps tendon rupture (M66.829: stiffness)
- • Symptom flares in Biceps tendon rupture correlating with hs-CRP & Erythrocyte in Biceps tendon rupture (M66.829: Sedimentation Rate) deviation outside hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M66.829)
- • Functional arthritis & joints impact requiring synovial fluid crystal/cell in Biceps tendon rupture (M66.829: analysis when effused) evaluation (M66.829)
Biceps tendon rupture Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | M66.829 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoarthritis, Gout & Joint Pain | NLM Clinical Tables |
| Diagnostic / Lab Marker: hs-CRP & Erythrocyte in Biceps tendon rupture (M66.829: Sedimentation Rate) | hs-CRP < 1.5 mg/L; ESR < 15 mm/hr (M66.829) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Weight-Bearing Joint Radiograph [Biceps tendon rupture M66.829] | Preserved joint-space width (M66.829) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Uric Acid in Biceps tendon rupture (M66.829: (Gout Target)) | < 6.0 mg/dL (< 5.0 mg/dL with tophi) (M66.829) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Biceps tendon rupture
Treatment selection for Biceps tendon rupture depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Biceps tendon rupture)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Validation of the Ankylosing Spondylitis Quality of Life assessment tool in: What a 325-Participant Study Found Our findings suggest that the ASQoL is an appropriate outcome measure in interventional clinical trials in patients with nr-axSpA. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation • 2021-03-15 • Phase III Randomized Trial | N = 325 | 93/100 | PMID 33128725 ↗ |
| New Insights on Intravenous Meloxicam Versus Ketorolac for Pain Control Following Total Joint: What a 223-Participant Study Found The use of IV meloxicam as part of a perioperative pain management protocol led to increased opioid consumption, longer lengths of stay, and a lower rate of same-day discharges than IV ketorolac. The Journal of arthroplasty • 2026-07-15 • Phase III Randomized Trial | N = 223 | 88/100 | PMID 41167538 ↗ |
| Can This Approach Help? Inside the Latest Research on A phase 3, randomized, gold-standard blind, active-controlled clinical trial to In TP2, efficacy, safety, immunogenicity, and how the body absorbs the medicine profiles were comparable between the TCZ, TCZ to BAT1806/BIIB800, and BAT1806/BIIB800 groups. Arthritis research & therapy • 2024-09-07 • Phase III Randomized Trial | N = 145 | 88/100 | PMID 39244595 ↗ |
| Can This Approach Help? Inside the Latest Research on Predictors of new bone erosion in autoimmune joint pain (rheumatoid arthritis) In RA patients treated with csDMARDs, new bone erosion predictors were seropositivity, elevated inflammatory markers, and baseline ES ≥3. Modern rheumatology • 2021-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 31826682 ↗ |
Biceps tendon rupture Patient Community & “People Like Me” Threads
Filter Biceps tendon rupture community threads and patient logs by age, biological sex, dosage, and treatment duration.